|
Name |
Tensyuic acid C
|
| Molecular Formula | C13H20O6 | |
| IUPAC Name* |
2-(6-ethoxy-6-oxohexyl)-3-methylidenebutanedioic acid
|
|
| SMILES |
CCOC(=O)CCCCCC(C(=C)C(=O)O)C(=O)O
|
|
| InChI |
InChI=1S/C13H20O6/c1-3-19-11(14)8-6-4-5-7-10(13(17)18)9(2)12(15)16/h10H,2-8H2,1H3,(H,15,16)(H,17,18)
|
|
| InChIKey |
STUMFFBVBKIJSG-UHFFFAOYSA-N
|
|
| Synonyms |
Tensyuic acid C; (-)-tensyuic acid C; CHEBI:133829; (-)-2-(6-ethoxy-6-oxohexyl)-3-methylenesuccinic acid; 2-(6-ethoxy-6-oxohexyl)-3-methylidenebutanedioic acid; (-)-2-(6-ethoxy-6-oxohexyl)-3-methylidenebutanedioic acid; (2Xi)-2-(6-ethoxy-6-oxohexyl)-3-methylenesuccinic acid; (2Xi)-2-(6-ethoxy-6-oxohexyl)-3-methylidenebutanedioic acid
|
|
| CAS | NA | |
| PubChem CID | 17757653 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 272.29 | ALogp: | 1.9 |
| HBD: | 2 | HBA: | 6 |
| Rotatable Bonds: | 11 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 101.0 | Aromatic Rings: | 0 |
| Heavy Atoms: | 19 | QED Weighted: | 0.36 |
| Caco-2 Permeability: | -5.775 | MDCK Permeability: | 0.00378713 |
| Pgp-inhibitor: | 0 | Pgp-substrate: | 0.001 |
| Human Intestinal Absorption (HIA): | 0.015 | 20% Bioavailability (F20%): | 0.003 |
| 30% Bioavailability (F30%): | 0.645 |
| Blood-Brain-Barrier Penetration (BBB): | 0.347 | Plasma Protein Binding (PPB): | 75.16% |
| Volume Distribution (VD): | 0.274 | Fu: | 24.08% |
| CYP1A2-inhibitor: | 0.008 | CYP1A2-substrate: | 0.066 |
| CYP2C19-inhibitor: | 0.025 | CYP2C19-substrate: | 0.051 |
| CYP2C9-inhibitor: | 0.002 | CYP2C9-substrate: | 0.9 |
| CYP2D6-inhibitor: | 0.017 | CYP2D6-substrate: | 0.091 |
| CYP3A4-inhibitor: | 0.016 | CYP3A4-substrate: | 0.008 |
| Clearance (CL): | 6.326 | Half-life (T1/2): | 0.889 |
| hERG Blockers: | 0.004 | Human Hepatotoxicity (H-HT): | 0.082 |
| Drug-inuced Liver Injury (DILI): | 0.075 | AMES Toxicity: | 0.003 |
| Rat Oral Acute Toxicity: | 0.039 | Maximum Recommended Daily Dose: | 0.004 |
| Skin Sensitization: | 0.418 | Carcinogencity: | 0.023 |
| Eye Corrosion: | 0.984 | Eye Irritation: | 0.97 |
| Respiratory Toxicity: | 0.044 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC002150 | ![]() |
0.679 | D0E4WR | ![]() |
0.349 | ||
| ENC002268 | ![]() |
0.638 | D0G2KD | ![]() |
0.333 | ||
| ENC003534 | ![]() |
0.408 | D0AY9Q | ![]() |
0.333 | ||
| ENC000543 | ![]() |
0.394 | D05PHH | ![]() |
0.310 | ||
| ENC000248 | ![]() |
0.391 | D0Z0MG | ![]() |
0.297 | ||
| ENC000758 | ![]() |
0.386 | D07JVS | ![]() |
0.293 | ||
| ENC003189 | ![]() |
0.369 | D02GIU | ![]() |
0.284 | ||
| ENC001015 | ![]() |
0.362 | D00MLW | ![]() |
0.276 | ||
| ENC001287 | ![]() |
0.361 | D0FD0H | ![]() |
0.276 | ||
| ENC001325 | ![]() |
0.352 | D02HFD | ![]() |
0.275 | ||